Skip to main content
Clinical Trials/ISRCTN35169306
ISRCTN35169306
Completed
Not Applicable

The effect of multi-level botulinum toxin treatment and intensive rehabilitation on walking ability in children with cerebral palsy

Vrije University Medical Centre (VUMC) (The Netherlands)0 sites47 target enrollmentAugust 4, 2005

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cerebral parese (cerebral palsy)
Sponsor
Vrije University Medical Centre (VUMC) (The Netherlands)
Enrollment
47
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 4, 2005
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Vrije University Medical Centre (VUMC) (The Netherlands)

Eligibility Criteria

Inclusion Criteria

  • 1\. Diagnosis of cerebral palsy (CP), hemiplegia or diplegia
  • 2\. Ability to walk with or without a walking aid, with or without an ankle\-foot orthosis
  • 2\. Gait characterised by persistent flexion of the hip and knee in mid\-stance when walking
  • 3\. Aged between 4 and 12 years

Exclusion Criteria

  • 1\. BTX treatment in lower extremities 16 weeks before inclusion
  • 2\. Orthopaedic surgery 24 weeks before inclusion
  • 3\. Contra\-indication for BTX\-A
  • 4\. Contra\-indication for general anaesthesia
  • 5\. Severe fixed contractures
  • 6\. Orthopaedic deformities, which have a bad influence on walking:
  • 6\.1\. (Sub)luxation of the hip with a migration index greater than 50 degrees
  • 6\.2\. Hip endorotation contracture greater than 15 degrees
  • 6\.3\. Flexion contracture of knee greater than 15 degrees
  • 7\. Presence of ataxia of dyskinesia

Outcomes

Primary Outcomes

Not specified

Similar Trials